Nasal Drug Delivery Systems Market, By Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), By Container Type (Non-pressurized Containers, and Pressurized Containers), By System Type (Multi-dose, Bi-dose, and Unit dose), By Therapeutic Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

The nasal drug delivery market was valued at US$51.20 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 6.1% to reach US$92.47 billion by 2030.

A nasal drug delivery system, which offers direct access to the systemic circulation and is an alternative to invasive administrations, is used to administer drugs through the nasal route. For treating common colds, nasal congestion, and allergic and non-allergic rhinitis, nasal drug delivery is the most recommended method of administration. Drug molecules can be delivered to the central nervous system through the intranasal route, which can pass through the blood-brain barrier. Using nasal drug delivery devices, medications are also administered orally for therapeutic and recreational purposes. Nasal medication administration is recommended for medications experiencing a significant first-pass effect. Additionally, the intranasal route delivers drug molecules to the central nervous system while avoiding the blood-brain barrier. Depending on how each drug is made, various nasal drug delivery systems are available. For example, liquid nasal preparations can be used with atomizers, nebulizers, spray pumps, inhalers, or droppers.